Clinical Trial Update: Inhaled Nitric Oxide for Pulmonary Hypertension and Bronchopulmonary Dysplasia [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/Phase 2 trial evaluating inhaled nitric oxide for Pulmonary Hypertension and Bronchopulmonary Dysplasia was terminated. Results were posted on 2025-01…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bronchopulmonary Dysplasia
• Pulmonary Hypertension

Drugs mentioned

• Inhaled nitric oxide (nitric oxide)

Snippet

Sponsor: AdventHealth | Conditions: Pulmonary Hypertension, Bronchopulmonary Dysplasia | Phase 1, Phase 2 | Status: TERMINATED | Results posted: 2025-01-15